These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12206401)

  • 1. Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole.
    Anil S; Samaranayake LP
    Oral Dis; 2002 Jul; 8(4):199-206. PubMed ID: 12206401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Brief Exposure to Drugs with Antifungal Properties on the Susceptibility of Oral Candida dubliniensis Isolates to Lysozyme and Lactoferrin.
    Ellepola ANB; Dassanayake RS; Khan Z
    Med Princ Pract; 2018; 27(6):523-530. PubMed ID: 30173211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of polyene, azole, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection.
    Anil S; Ellepola AN; Samaranayake LP
    Mycopathologia; 2002; 153(4):179-85. PubMed ID: 12014477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief exposure to antimycotics reduces the extracellular phospholipase activity of Candida albicans and Candida tropicalis.
    Anil S; Samaranayake LP
    Chemotherapy; 2003 Sep; 49(5):243-7. PubMed ID: 14504435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
    Ellepola AN; Khajah R; Jayatilake S; Samaranayake L; Sharma P; Khan Z
    J Appl Oral Sci; 2015; 23(4):412-8. PubMed ID: 26398514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.
    Anil S; Hashem M; Vellappally S; Patil S; Bandara HM; Samaranayake LP
    Mycopathologia; 2014 Oct; 178(3-4):207-15. PubMed ID: 25142726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin.
    Ellepola AN; Panagoda GJ; Samaranayake LP
    Oral Microbiol Immunol; 1999 Dec; 14(6):358-63. PubMed ID: 10895691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
    Ellepola AN; Samaranayake LP
    Arch Oral Biol; 1998 Dec; 43(12):999-1007. PubMed ID: 9877331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans.
    Samaranayake YH; Samaranayake LP; Wu PC; So M
    APMIS; 1997 Nov; 105(11):875-83. PubMed ID: 9393559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
    Ellepola AN; Samaranayake LP
    Oral Dis; 1998 Dec; 4(4):260-7. PubMed ID: 10200705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
    Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 1998 May; 27(5):213-9. PubMed ID: 9682984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular phospholipase production of oral Candida albicans isolates from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to polyene, echinocandin and azole antimycotics.
    Ellepola AN; Samaranayake LP; Khan ZU
    Braz J Microbiol; 2016; 47(4):911-916. PubMed ID: 27522928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.
    Ellepola AN; Jayathilake JA; Sharma PN; Khan ZU
    J Investig Clin Dent; 2016 Nov; 7(4):424-430. PubMed ID: 26059506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates.
    Egusa H; Ellepola AN; Nikawa H; Hamada T; Samaranayake LP
    J Oral Pathol Med; 2000 May; 29(5):206-13. PubMed ID: 10801037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
    Ellepola AN; Joseph BK; Samaranayake LP; Bandara HM; Khan ZU
    J Investig Clin Dent; 2016 May; 7(2):149-57. PubMed ID: 25388637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
    Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
    J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.